Randomized trial demonstrates the high sensitivity of a modified electrode for detecting aspirin, indicating its potential in real-world applications.
A copper–molybdenum–phosphate (CuMoP)‐modified screen‐printed carbon electrode (SPCE) was developed (mSPCE) via one‐step potentiostatic codeposition for the electrochemical detection of aspirin (acetylsalicylic acid, ASA). Microscopic and spectroscopic analyses confirmed a uniform, granular CuMoP film with mixed‐valence Cu + /Cu 2+ and Mo 6+ centers coordinated by phosphate groups, thereby enhancing electron–proton coupling. The sensor exhibited a well‐defined irreversible oxidation peak at 0.866 V (pH 3.0), showed highly sensitive detection for ASA, and followed a diffusion‐controlled two‐electron mechanism. Differential pulse voltammetry revealed an excellent linear response ( I = 0.036 + 0.012 C, R 2 = 0.9979) over 2.0–92.6 µM, with a limit of detection of 1.5 µM and a quantification limit of 5.0 µM. The mSPCE displayed high stability (RSD = 2.6%), reproducibility (RSD = 5.4%), and recovery of 91.21%–103.52% for pharmaceutical tablets. Outstanding selectivity against 100‐fold interfering species highlights the synergistic Cu–Mo–P redox network as an efficient, low‐cost, and portable platform for sensitive determination of ASA in real samples.
No takes yet. Share an insight, caveat, or question.
Wan et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: